S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

CELZ Creative Medical Technology Holdings Inc

4.575

0.135 (3.04%)

02 May 2024 - Closed

Delayed by 15 minutes

Creative Medical stock rises 18% on collaboration agreement for ImmCelz

To read the full story on Seeking Alpha, click here.

Creative Medical Technol... (NASDAQ:CELZ)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Creative Medical Technol... Charts.

Creative Medical Technol... (NASDAQ:CELZ)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Creative Medical Technol... Charts.

Creative Medical Technology Holdings Inc News

Creative Medical Technology Holdings Provides Corporate Update
Thursday 28 March 2024 (1 month ago) • Business Wire

Creative Medical Technology Holdings Inc. Announces FDA Authorization for Groundbreaking Type 1 Diabetes Prevention Therapy Under Expanded Access
Friday 8 March 2024 (2 months ago) • Business Wire

Biotech Finds Mid-Week Success Following FDA Announcement
Thursday 7 March 2024 (2 months ago) • AllPennyStocks.com

Creative Medical Technology Holdings, Inc. Receives FDA Orphan Drug Designation for CELZ-101 in Key Transplantation Therapy
Wednesday 6 March 2024 (2 months ago) • Business Wire

Form 8-K - Current report
Thursday 21 December 2023 (4 months ago) • Edgar (US Regulatory)

Creative Medical Technology Holdings Provides Corporate Update
Thursday 16 November 2023 (6 months ago) • PR Newswire (US)

Form DEF 14A - Other definitive proxy statements
Saturday 4 November 2023 (6 months ago) • Edgar (US Regulatory)

Creative Medical Technology Holdings Announces IRB Approval for FDA Cleared Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ ("CELZ-201-DDT") Novel Cell Therapy to Treat Chronic Lower Back Pain
Tuesday 10 October 2023 (7 months ago) • PR Newswire (US)

Creative Medical Technology Holdings Receives FDA Clearance to Initiate a Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ (CELZ-201-DDT) for the Treatment of Chronic Lower Back Pain
Tuesday 19 September 2023 (7 months ago) • PR Newswire (US)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Saturday 12 August 2023 (9 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 30 June 2023 (10 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 28 June 2023 (10 months ago) • Edgar (US Regulatory)

More Creative Medical Technology Holdings Inc News Articles

Verizon Communications

Gold vs US Dollar

S&P ASX 300 Metals and M...

AUD vs US Dollar

Commonwealth Bank Of Aus...

Australian SE All Ordina...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions